{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:49:44Z","timestamp":1791409784467,"version":"4.3.3"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004006","name":"Istanbul University Scientific Research Projects Unit","doi-asserted-by":"publisher","award":["TAB-2025-41700"],"award-info":[{"award-number":["TAB-2025-41700"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110304","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:37:00Z","timestamp":1785253020000},"page":"110304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Phenylalanine- and tryptophan-based hydrazone hybrids targeting the VEGF axis and caspase-mediated apoptosis: Design, synthesis, and biological evaluation"],"prefix":"10.1016","volume":"181","author":[{"given":"Merve","family":"Camci Eren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge Sultan","family":"Zengin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcl","family":"\u00d6zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilg\u00fcn L.","family":"Karali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110304_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128258","article-title":"Angiokinase inhibition of VEGFR-2, PDGFR and FGFR and cell growth inhibition in lung cancer: design, synthesis, biological evaluation and molecular docking of novel azaheterocyclic coumarin derivatives","volume":"48","author":"Ahmed","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110304_bb0010","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1186\/s12967-024-05893-2","article-title":"Discovery of novel VEGFR2 inhibitors against non-small cell lung cancer based on fingerprint-enhanced graph attention convolutional network","volume":"22","author":"Wang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110304_bb0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1080\/14756366.2021.1915302","article-title":"Development of 3-methyl\/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells","volume":"36","author":"Al-Sanea","year":"2021","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110304_bb0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.biotechadv.2019.02.012","article-title":"Apoptosis: A mammalian cell bioprocessing perspective","volume":"37","author":"Grilo","year":"2019","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.bioorg.2026.110304_bb0025","doi-asserted-by":"crossref","unstructured":"Bildik, A.B., \u0130., Inhibition of apoptotic pathways in cancer. Turk. Klin. J. Vet. Sci., 2018. 9(2): p. 42\u201351. DOI: https:\/\/doi.org\/10.5336\/vetsci.2018-62141.","DOI":"10.5336\/vetsci.2018-62141"},{"key":"10.1016\/j.bioorg.2026.110304_bb0030","unstructured":"Celepli, S.B., \u0130.; Celepli, P.; Karagin, P.H., APOPTOZ VE APOPTOT\u0130K YOLLARIN G\u00d6ZDEN GE\u00c7\u0130R\u0130LMES\u0130. G\u00fcncel Gastroenterol., 2020. 24(3): p. 103\u2013111."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110304_bb0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12943-015-0310-8","article-title":"Vascular endothelial growth factor is an autocrine growth factor, signaling through neuropilin-1 in non-small cell lung cancer","volume":"14","author":"Barr","year":"2015","journal-title":"Mol. Cancer"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110304_bb0050","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1172\/JCI65385","article-title":"Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer","volume":"123","author":"Chatterjee","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110304_bb0055","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2967\/jnumed.115.166462","article-title":"PET imaging of VEGFR-2 expression in lung cancer with 64Cu-labeled Ramucirumab","volume":"57","author":"Luo","year":"2016","journal-title":"J. Nucl. Med."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110304_bb0060","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11596-011-0571-4","article-title":"Effects of exogenous VEGF(165)b on invasion and migration of human lung adenocarcinoma A549 cells","volume":"31","author":"Chen","year":"2011","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110304_bb0065","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1007\/s11033-012-2383-4","article-title":"Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549","volume":"40","author":"Wang","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110304_bb0075","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-022-01310-7","article-title":"Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy","volume":"15","author":"Liu","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110304_bb0080","first-page":"165","article-title":"Phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin (PI3K-Akt-mTOR) signaling pathway in non-small cell lung cancer","volume":"4","author":"Yip","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110304_bb0085","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/s41392-021-00828-5","article-title":"Targeting PI3K\/Akt signal transduction for cancer therapy","volume":"6","author":"He","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2026.110304_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.869672","article-title":"Bax\/Bcl-2 cascade is regulated by the EGFR pathway: therapeutic targeting of non-small cell lung cancer","volume":"12","author":"Alam","year":"2022","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110304_bb0095","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1158\/1078-0432.CCR-04-1482","article-title":"Caspase regulation in non\u2013small cell lung cancer and its potential for therapeutic exploitation","volume":"11","author":"Fennell","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110304_bb0105","first-page":"123","article-title":"Clinical advances in the development of novel VEGFR2 inhibitors","volume":"2","author":"Fontanella","year":"2014","journal-title":"Ann. Transl. Med."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110304_bb0110","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S1470-2045(19)30634-5","article-title":"Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Nakagawa","year":"2019","journal-title":"Lancet Oncol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110304_bb0115","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1111\/cas.14801","article-title":"VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers","volume":"112","author":"Watanabe","year":"2021","journal-title":"Cancer Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110304_bb0120","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.bjc.6602109","article-title":"Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models","volume":"91","author":"Dev","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioorg.2026.110304_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29225341","article-title":"Targeting vascular endothelial growth factor receptor 2 (VEGFR-2): latest insights on synthetic strategies","volume":"29","author":"Marques","year":"2024","journal-title":"Molecules"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110304_bb0130","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1080\/07391102.2019.1635915","article-title":"Protein\u2013ligand interaction-guided discovery of novel VEGFR-2 inhibitors","volume":"38","author":"Zhang","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110304_bb0160","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/1735-5362.363593","article-title":"Synthesis of oxamide-hydrazone hybrid derivatives as potential anticancer agents","volume":"18","author":"Dehbid","year":"2023","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110304_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138634","article-title":"Synthesis, anti-inflammatory, antibacterial, and antioxidant evaluation of novel pyrazole-linked hydrazone derivatives","volume":"1312","author":"Kamat","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"18","key":"10.1016\/j.bioorg.2026.110304_bb0170","doi-asserted-by":"crossref","first-page":"10562","DOI":"10.1093\/nar\/gkac809","article-title":"Hydrazone chemistry-mediated CRISPR\/Cas12a system for bacterial analysis","volume":"50","author":"Sheng","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110304_bb0175","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ardp.201200449","article-title":"Synthesis, cytotoxicity, and pro-apoptosis activity of Etodolac hydrazide derivatives as anticancer agents","volume":"346","author":"\u00c7\u0131kla","year":"2013","journal-title":"Arch. Pharm."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110304_bb0180","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1007\/s00044-013-0550-3","article-title":"Synthesis and characterization of flurbiprofen hydrazide derivatives as potential anti-HCV, anticancer and antimicrobial agents","volume":"22","author":"\u00c7\u0131kla","year":"2013","journal-title":"Med. Chem. Res."},{"issue":"33","key":"10.1016\/j.bioorg.2026.110304_bb0185","doi-asserted-by":"crossref","first-page":"26860","DOI":"10.1039\/D5RA04425A","article-title":"Thiazole conjugated amino acid derivatives as potent cytotoxic agents","volume":"15","author":"Le","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.bioorg.2026.110304_bb0190","article-title":"Dual-targeted therapy circumvents non-genetic drug resistance to targeted therapy","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioorg.2026.110304_bb0195","doi-asserted-by":"crossref","first-page":"106425","DOI":"10.1016\/j.bioorg.2023.106425","article-title":"Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy","volume":"133","author":"Liu","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.110304_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113448","article-title":"Tailor-made amino acids in the design of small-molecule blockbuster drugs","volume":"220","author":"Han","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110304_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112736","article-title":"Cyclic tailor-made amino acids in the design of modern pharmaceuticals","volume":"208","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110304_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111826","article-title":"Applications of fluorine-containing amino acids for drug design","volume":"186","author":"Mei","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110304_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28093651","article-title":"New approved drugs appearing in the pharmaceutical market in 2022 featuring fragments of tailor-made amino acids and fluorine","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"issue":"48","key":"10.1016\/j.bioorg.2026.110304_bb0210","doi-asserted-by":"crossref","first-page":"45502","DOI":"10.1021\/acsomega.3c05488","article-title":"Design, synthesis, and functional studies on noscapine and Cotarnine amino acid derivatives as antitumor agents","volume":"8","author":"Davarzani","year":"2023","journal-title":"ACS Omega"},{"issue":"6 Suppl 1","key":"10.1016\/j.bioorg.2026.110304_bb0215","doi-asserted-by":"crossref","first-page":"1504S","DOI":"10.1093\/jn\/137.6.1504S","article-title":"Cation-pi interactions involving aromatic amino acids","volume":"137","author":"Dougherty","year":"2007","journal-title":"J. Nutr."},{"key":"10.1016\/j.bioorg.2026.110304_bb0220","doi-asserted-by":"crossref","unstructured":"H\u00e4fliger, P. and R.P. Charles, The L-type amino acid transporter LAT1-an emerging target in Cancer. Int. J. Mol. Sci., 2019. 20(10). DOI: https:\/\/doi.org\/10.3390\/ijms20102428 From NLM.","DOI":"10.3390\/ijms20102428"},{"key":"10.1016\/j.bioorg.2026.110304_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107964","article-title":"Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics","volume":"230","author":"Kanai","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110304_bb0230","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200548","article-title":"Anticancer agents incorporating the N-acylhydrazone scaffold: progress from 2017 to present","volume":"356","author":"Kassab","year":"2023","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"16","key":"10.1016\/j.bioorg.2026.110304_bb0235","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26164908","article-title":"Synthesis of novel N-Acylhydrazones and their C-N\/N-N bond conformational characterization by NMR spectroscopy","volume":"26","author":"Munir","year":"2021","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110304_bb0240","doi-asserted-by":"crossref","first-page":"992","DOI":"10.2174\/1871520619666190408133141","article-title":"Dual anti-cancer and anti-itch activity of PD176252 analogues: design, synthesis and biological evaluation","volume":"19","author":"Yu","year":"2019","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.bioorg.2026.110304_bb0245","series-title":"Nowe pochodne peptydowe, zw\u0142aszcza stosowania w terapii nowotwor\u00f3w (Polish Patent Application No. P.438528)","author":"Lipi\u0144ski","year":"2023"},{"key":"10.1016\/j.bioorg.2026.110304_bb0200","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.biopha.2018.05.134","article-title":"Survivin is critically involved in VEGFR2 signaling-mediated esophageal cancer cell survival","volume":"107","author":"Meng","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110304_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188866","article-title":"Therapeutic strategies of dual-target small molecules to overcome drug resistance in cancer therapy","volume":"1878","author":"Ye","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bioorg.2026.110304_bb0250","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejmech.2016.02.029","article-title":"Increasing the binding affinity of VEGFR-2 inhibitors by extending their hydrophobic interaction with the active site: design, synthesis and biological evaluation of 1-substituted-4-(4-methoxybenzyl)phthalazine derivatives","volume":"113","author":"Eldehna","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110304_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202504783","article-title":"Design, synthesis, and evaluation of hydrazide-based VEGFR-2 inhibitors with antiangiogenic potential","volume":"11","author":"Fatale","year":"2026","journal-title":"ChemistrySelect"},{"issue":"4(supplementary)","key":"10.1016\/j.bioorg.2026.110304_bb0260","first-page":"1509","article-title":"Design, synthesis and biological evaluations of 2-aminothiazole scaffold containing amino acid moieties as anti-cancer agents","volume":"34","author":"Ilyas","year":"2021","journal-title":"Pak. J. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2026.110304_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117963","article-title":"Amino acid\u2013modified chalcone derivatives with in vitro and in vivo efficacy against colon cancer","volume":"297","author":"El-Haggar","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110304_bb0270","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.21597\/jist.902184","article-title":"4-((3-(Triflorometil)piridin-2-il)oksi)benzohidrazit Birimi \u0130\u00e7eren Yeni Hidrazon T\u00fcrevlerinin Sentezi","volume":"11","author":"K\u00f6se","year":"2021","journal-title":"I\u011fd\u0131r \u00dcniversitesi Fen Bilimleri Enstit\u00fcs\u00fc Dergisi"},{"key":"10.1016\/j.bioorg.2026.110304_bb0275","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Palacios, S., et al., New insights into Acylhydrazones E\/Z isomerization: an experimental and theoretical approach. Int. J. Mol. Sci., 2023. 24(19). DOI: https:\/\/doi.org\/10.3390\/ijms241914739 From NLM.","DOI":"10.3390\/ijms241914739"},{"issue":"51","key":"10.1016\/j.bioorg.2026.110304_bb0280","doi-asserted-by":"crossref","first-page":"18269","DOI":"10.1021\/ja909149z","article-title":"A pH activated configurational rotary switch: controlling the E\/Z isomerization in Hydrazones","volume":"131","author":"Landge","year":"2009","journal-title":"J. Am. Chem. Soc."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110304_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25133082","article-title":"Effect of a =X-NH-fragment, (X = C, N), on Z\/E isomerization and ON\/OFF functionality of isatin arylhydrazones, ((arylamino)methylene)indolin-2-ones and their anions","volume":"25","author":"Tisovsk\u00fd","year":"2020","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110304_bb0290","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/bip.22852","article-title":"Conformational preferences and synthesis of isomers Z and E of oxazole-dehydrophenylalanine","volume":"106","author":"Sta\u015b","year":"2016","journal-title":"Biopolymers"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110304_bb0295","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/j.bmcl.2009.02.116","article-title":"Synthesis and antiviral activities of novel acylhydrazone derivatives targeting HIV-1 capsid protein","volume":"19","author":"Tian","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110304_bb0300","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.bmc.2010.02.003","article-title":"SAR and molecular mechanism study of novel acylhydrazone compounds targeting HIV-1 CA","volume":"18","author":"Jin","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2026.110304_bb0305","doi-asserted-by":"crossref","DOI":"10.3390\/nu10081021","article-title":"Anti-Cancer natural products and their bioactive compounds inducing ER stress-mediated apoptosis: A review","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.bioorg.2026.110304_bb0310","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1600-0854.2006.00462.x","article-title":"Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting, and degradation in endothelial cells","volume":"7","author":"Ewan","year":"2006","journal-title":"Traffic"},{"key":"10.1016\/j.bioorg.2026.110304_bb0315","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/cdd.2009.152","article-title":"VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2","volume":"17","author":"Zhang","year":"2010","journal-title":"Cell Death Differ."},{"issue":"46","key":"10.1016\/j.bioorg.2026.110304_bb0320","doi-asserted-by":"crossref","first-page":"30336","DOI":"10.1074\/jbc.273.46.30336","article-title":"Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3\u2032-kinase\/Akt signal transduction pathway. Requirement for Flk-1\/KDR activation","volume":"273","author":"Gerber","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110304_bb0325","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2011.00051","article-title":"PI3K\/AKT\/mTOR pathway in angiogenesis","volume":"4","author":"Karar","year":"2011","journal-title":"Front. Mol. Neurosci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110304_bb0330","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling - in control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110304_bb0335","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.intimp.2008.11.020","article-title":"The mechanisms on apoptosis by inhibiting VEGF expression in human breast cancer cells","volume":"9","author":"Ge","year":"2009","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110304_bb0340","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejheart.2006.10.007","article-title":"Intramyocardial injection of vascular endothelial growth factor gene improves cardiac performance and inhibits cardiomyocyte apoptosis","volume":"9","author":"Ruixing","year":"2007","journal-title":"Eur. J. Heart Fail."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110304_bb0345","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0165-6147(00)01719-3","article-title":"Hormesis: U-shaped dose responses and their centrality in toxicology","volume":"22","author":"Calabrese","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.bioorg.2026.110304_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9030718","article-title":"Biphasic dose-response induced by phytochemicals: experimental evidence","volume":"9","author":"Jodynis-Liebert","year":"2020","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110304_bb0355","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1177\/0960327110383625","article-title":"Resveratrol commonly displays hormesis: occurrence and biomedical significance","volume":"29","author":"Calabrese","year":"2010","journal-title":"Hum. Exp. Toxicol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110304_bb0360","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1242\/jcs.163774","article-title":"Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy","volume":"128","author":"Domigan","year":"2015","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110304_bb0365","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/tox.22853","article-title":"Apoptosis induction and ERK\/NF-kappaB inactivation are associated with magnolol-inhibited tumor progression in hepatocellular carcinoma in vivo","volume":"35","author":"Tsai","year":"2020","journal-title":"Environ. Toxicol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110304_bb0370","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s12967-024-05155-1","article-title":"VEGFR2 blockade inhibits glioblastoma cell proliferation by enhancing mitochondrial biogenesis","volume":"22","author":"Guo","year":"2024","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.bioorg.2026.110304_bb0375","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","article-title":"Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates","volume":"21","author":"Doak","year":"2014","journal-title":"Chem. Biol."},{"issue":"14","key":"10.1016\/j.bioorg.2026.110304_bb0380","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1007\/s10973-021-11089-3","article-title":"Tryptophan methyl ester: a proposal of the thermal decomposition mechanism","volume":"147","author":"Justino","year":"2022","journal-title":"J. Therm. Anal. Calorim."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110304_bb0385","doi-asserted-by":"crossref","DOI":"10.22159\/ijpps.2017v9i1.15250","article-title":"Design, synthesis and preliminary pharmacological evaluation of new metformin derivatives","volume":"9","author":"Mahdi","year":"2016","journal-title":"Int J Pharm Pharm Sci"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110304_bb0390","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/jm0340400","article-title":"Identification of N,N-disubstituted phenylalanines as a novel class of inhibitors of hepatitis C NS5B polymerase","volume":"46","author":"Chan","year":"2003","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2026.110304_bb0395","doi-asserted-by":"crossref","first-page":"20073","DOI":"10.1021\/acsomega.3c02361","article-title":"Novel N-acyl Hydrazone compounds as promising anticancer agents: synthesis and molecular docking studies","volume":"8","author":"Biliz","year":"2023","journal-title":"ACS Omega"},{"issue":"23","key":"10.1016\/j.bioorg.2026.110304_bb0415","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222312827","article-title":"The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis","volume":"22","author":"Ghasemi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110304_bb0420","doi-asserted-by":"crossref","first-page":"17931","DOI":"10.1021\/acs.jmedchem.4c02052","article-title":"Dose-response curves and the determination of IC50 and EC50 values","volume":"67","author":"Srinivasan","year":"2024","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110304_bb0425","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/mutage\/geab005","article-title":"A comparative analysis of the mutagenicity of platinum-containing chemotherapeutic agents reveals direct and indirect mutagenic mechanisms","volume":"36","author":"Szikriszt","year":"2021","journal-title":"Mutagenesis"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110304_bb0430","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094931","article-title":"Effective drug concentration and selectivity depends on fraction of primitive cells","volume":"22","author":"Lica","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2026.110304_bb0435","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/bs.podrm.2020.07.005","article-title":"Validation of in-vitro bioassay methods: application in herbal drug research","volume":"46","author":"Indrayanto","year":"2021","journal-title":"Profiles Drug Subst. Excip. Relat. Methodol."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110304_bb0440","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1177\/0748233718763517","article-title":"Cadmium telluride quantum dots induce apoptosis in human breast cancer cell lines","volume":"34","author":"Naderi","year":"2018","journal-title":"Toxicol. Ind. Health"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110304_bb0445","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2203\/dose-response.09-049.Reynolds","article-title":"Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer","volume":"8","author":"Reynolds","year":"2010","journal-title":"Dose-Response"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110304_bb0450","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.homp.2015.02.007","article-title":"Hormesis: principles and applications","volume":"104","author":"Calabrese","year":"2015","journal-title":"Homeopathy"},{"key":"10.1016\/j.bioorg.2026.110304_bb0455","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/bs.ctdb.2016.10.001","article-title":"VEGF receptor tyrosine kinases: key regulators of vascular function","volume":"123","author":"\u00c1lvarez-Aznar","year":"2017","journal-title":"Curr. Top. Dev. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:57:37Z","timestamp":1791406657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826008400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":83,"alternative-id":["S0045206826008400"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110304","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenylalanine- and tryptophan-based hydrazone hybrids targeting the VEGF axis and caspase-mediated apoptosis: Design, synthesis, and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110304"}}